DK1907536T3 - Cellelinie til produktion af coronavira - Google Patents

Cellelinie til produktion af coronavira

Info

Publication number
DK1907536T3
DK1907536T3 DK06792538.8T DK06792538T DK1907536T3 DK 1907536 T3 DK1907536 T3 DK 1907536T3 DK 06792538 T DK06792538 T DK 06792538T DK 1907536 T3 DK1907536 T3 DK 1907536T3
Authority
DK
Denmark
Prior art keywords
coronaviruses
production
cell line
relates
cov
Prior art date
Application number
DK06792538.8T
Other languages
English (en)
Inventor
Den Brink Edward Norbert Van
Meulen Jan Henrik Ter
Original Assignee
Crucell Holland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holland Bv filed Critical Crucell Holland Bv
Application granted granted Critical
Publication of DK1907536T3 publication Critical patent/DK1907536T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20051—Methods of production or purification of viral material
    • C12N2770/20052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK06792538.8T 2005-07-22 2006-07-21 Cellelinie til produktion af coronavira DK1907536T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70202905P 2005-07-22 2005-07-22
EP05106768 2005-07-22
PCT/EP2006/064489 WO2007010028A1 (en) 2005-07-22 2006-07-21 Cell line for producing coronaviruses

Publications (1)

Publication Number Publication Date
DK1907536T3 true DK1907536T3 (da) 2010-07-19

Family

ID=35445861

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06792538.8T DK1907536T3 (da) 2005-07-22 2006-07-21 Cellelinie til produktion af coronavira

Country Status (10)

Country Link
US (1) US7888102B2 (da)
EP (1) EP1907536B1 (da)
JP (1) JP5137829B2 (da)
KR (1) KR101274790B1 (da)
CN (1) CN101228267B (da)
AT (1) ATE463559T1 (da)
AU (1) AU2006271666B2 (da)
CA (1) CA2616221C (da)
DK (1) DK1907536T3 (da)
WO (1) WO2007010028A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2531684C (en) * 2003-07-22 2014-03-11 Crucell Holland B.V. Binding molecules against sars-coronavirus and uses thereof
EP1907536B1 (en) 2005-07-22 2010-04-07 Crucell Holland B.V. Cell line for producing coronaviruses
JP5161882B2 (ja) 2006-09-07 2013-03-13 クルセル ホランド ベー ヴェー インフルエンザウイルスｈ５ｎ１を中和しうるヒト結合性分子およびその使用
CN111273016B (zh) * 2020-02-26 2021-06-15 浙江诺迦生物科技有限公司 一种基于s蛋白配体与ace2受体竞争法层析的冠状病毒快速检测的试剂盒
WO2021207303A1 (en) * 2020-04-07 2021-10-14 Alsatech, Inc. Immune stimulation against coronavirus infections
US12194157B2 (en) 2020-04-09 2025-01-14 Finncure Oy Carrier for targeted delivery to a host
EP4132478A1 (en) 2020-04-09 2023-02-15 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses
EP4136095A1 (en) 2020-04-17 2023-02-22 Regents of the University of Minnesota Sars-cov-2 spike receptor binding domain and compositions and methods thereof
WO2021214467A1 (en) * 2020-04-23 2021-10-28 Cellbio A diagnostic tool improvement comprising a pathogen binding molecule
CN111575242A (zh) * 2020-06-04 2020-08-25 广东源心再生医学有限公司 一种用于COVID-19药物筛选的iPSC-nCoVN细胞模型及其建立和使用方法
US12156908B2 (en) 2020-07-01 2024-12-03 Regents Of The University Of Minnesota Virus like nanoparticle compositions and methods thereof
WO2022037699A1 (en) * 2020-08-21 2022-02-24 Westlake University Engineered ace2 oligomers and uses thereof
WO2022159433A1 (en) 2021-01-20 2022-07-28 Singh Biotechnology, Llc Therapeutics directed against coronavirus

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0833934T2 (sl) * 1995-06-15 2013-04-30 Crucell Holland B.V. Pakirni sistemi za humani rekombinantni adenovirus za uporabo v genski terapiji
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
ATE519855T1 (de) 1999-05-17 2011-08-15 Crucell Holland Bv Rekombinantes adenovirus des serotyps ad11
EP1103610A1 (en) * 1999-11-26 2001-05-30 Introgene B.V. Production of vaccines from immortalised mammalian cell lines
FR2828405B1 (fr) 2001-08-09 2005-06-24 Virbac Sa Vaccin anti-coronavirus
DE60330795D1 (de) * 2002-11-08 2010-02-11 Crucell Holland Bv Impfstoff gegen west nile virus
EP1633775A2 (en) 2003-06-13 2006-03-15 Crucell Holland B.V. Antigenic peptides of sars coronavirus and uses thereof
WO2005012337A2 (en) 2003-07-15 2005-02-10 Crucell Holland B.V. Antigenic peptides of sars coronavirus and uses thereof
EP1646645A1 (en) 2003-07-21 2006-04-19 Crucell Holland B.V. Antigenic peptides of sars coronavirus and uses thereof
CA2531684C (en) 2003-07-22 2014-03-11 Crucell Holland B.V. Binding molecules against sars-coronavirus and uses thereof
WO2005047459A2 (en) 2003-08-04 2005-05-26 University Of Massachusetts Sars nucleic acids, proteins, antibodies, and uses thereof
WO2005032487A2 (en) * 2003-10-06 2005-04-14 The Brigham And Women's Hospital, Inc. Angiotensin-converting enzyme-2 as a receptor for the sars coronavirus
EP1907536B1 (en) 2005-07-22 2010-04-07 Crucell Holland B.V. Cell line for producing coronaviruses

Also Published As

Publication number Publication date
US7888102B2 (en) 2011-02-15
JP2009502128A (ja) 2009-01-29
EP1907536A1 (en) 2008-04-09
AU2006271666B2 (en) 2011-04-07
WO2007010028A1 (en) 2007-01-25
CA2616221C (en) 2011-07-05
AU2006271666A1 (en) 2007-01-25
CN101228267B (zh) 2013-01-23
EP1907536B1 (en) 2010-04-07
CA2616221A1 (en) 2007-01-25
ATE463559T1 (de) 2010-04-15
CN101228267A (zh) 2008-07-23
KR20080033270A (ko) 2008-04-16
US20090098530A1 (en) 2009-04-16
KR101274790B1 (ko) 2013-06-13
JP5137829B2 (ja) 2013-02-06

Similar Documents

Publication Publication Date Title
WO2010088633A3 (en) Novel cell lines and methods
WO2009039307A3 (en) Hydrogels and methods for producing and using the same
IL229348A0 (en) Methods for producing activated dendritic cells
NL1026467A1 (nl) Composiet semipermeabel membraan, alsmede productiewerkwijze daarvoor.
WO2009102569A3 (en) Cell lines and methods for making and using them
WO2008021156A3 (en) Antibodies to il-17a
CY1113985T1 (el) Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξυαμιδο-πυριδινο βενζοϊκων οξεων
DK3336074T3 (da) Fremgangsmåde til produktion af fluorinerede, organiske forbindelser
WO2009149956A3 (en) Fusion protein and use thereof
EG25151A (en) Process for hydrogen production.
EP2586611A4 (en) POROUS COMPOSITE MEMBRANE, METHOD FOR PRODUCING A POROUS COMPOUND MEMBRANE AND BATTERY SUBSTANCE THEREWITH
DK1907536T3 (da) Cellelinie til produktion af coronavira
WO2010078952A3 (de) Strukturierte gasdiffusionselektrode für elektrolysezellen
DE602005026492D1 (de) Bipolarplatte für Brennstoffzelle
DK2174371T3 (da) Fremgangsmåde til fremstilling af en brændselscelle
WO2008047113A3 (en) Ethanol production
DE602007006258D1 (de) Ionenaustausch-Membranelektrolyseur
DK1851815T3 (da) Fremgangsmåde til fremstilling af en brændselscellekatode
DE602005024180D1 (de) Erzeugungssystem für brennstoffzellen des polymer-elektrolyttyps
DK1976960T3 (da) Fremgangsmåde til fremstilling af biodiesel
SG170081A1 (en) Method of patterning and product(s) obtained therefrom
DK2147133T3 (da) Elektrode til membranelektrolyseceller
DE602006014676D1 (de) Festpolymerelektrolyt-membran, herstellungsverfahren dafür und brennstoffzelle
PL2300606T3 (pl) Sposób wytwarzania hydrolizatu kazeiny
TW200740769A (en) Novel process